Search filters
Filters
Clear All

Phase

  • 1
  • 1
  • 1
  • 1

Found 1 Thrombocytopenia and Thrombocytopenia Prevention trials

A listing of Thrombocytopenia and Thrombocytopenia Prevention medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A phase 3, randomized, double-blind study of ianalumab (VAY736) versus placebo in addition to first-line corticosteroids in primary immune thrombocytopenia

99 years and younger
All genders
To demonstrate that the addition of ianalumab to standard first-line corticosteroids prolongs Time to Treatment Failure compared to Corticosteroids alone in participants with primary ITP. ITP means immune thrombocytopenia. Time from randomization to treatment failure which is defined as Platelet count below 30G/L after 8 weeks from randomization. Need for …
Learn More